GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Capex-to-Operating-Cash-Flow

Changmao Biochemical Engineering Co (HKSE:00954) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Changmao Biochemical Engineering Co's Capital Expenditure for the six months ended in Dec. 2024 was HK$-11.27 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2024 was HK$-6.12 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Changmao Biochemical Engineering Co Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Capex-to-Operating-Cash-Flow Chart

Changmao Biochemical Engineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 - 11.39 - -

Changmao Biochemical Engineering Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3.66 - -

Competitive Comparison of Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow

For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow falls into.


;
;

Changmao Biochemical Engineering Co Capex-to-Operating-Cash-Flow Calculation

Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-68.294) / -34.504
=N/A

Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-11.267) / -6.12
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changmao Biochemical Engineering Co  (HKSE:00954) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Changmao Biochemical Engineering Co Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Changmao Biochemical Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
Executives
Leng Yixin 2202 Interest of your spouse
Rui Xinsheng 2101 Beneficial owner

Changmao Biochemical Engineering Co Headlines

No Headlines